| |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
AB Establishment Expenses | 63 949.00 | 63 949.00 | | 63 949.00 |
BF Loans | | | | |
BJ TOTAL (I) | 7 708 257.00 | 4 746 749.00 | 2 961 508.00 | 7 708 257.00 |
BX Customers and related accounts | 783 445.00 | | 783 445.00 | 783 445.00 |
BZ Other receivables | 4 164.00 | | 4 164.00 | 4 164.00 |
CF Cash and cash equivalents | 10 830 349.00 | | 10 830 349.00 | 10 830 349.00 |
CJ TOTAL (II) | 11 617 959.00 | | 11 617 959.00 | 11 617 959.00 |
CO Grand total (0 to V) | 19 326 216.00 | 4 746 749.00 | 14 579 467.00 | 19 326 216.00 |
CS Evaluated investments - equity method | 7 644 308.00 | 4 682 800.00 | 2 961 508.00 | 7 644 308.00 |
| |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | | |
DA Share or individual capital | 7 006 355.00 | 7 006 355.00 | | 7 006 355.00 |
DB Share, merger, contribution premiums, etc. | 183 000.00 | 183 000.00 | | 183 000.00 |
DD Legal reserve (1) | 411 138.00 | 411 138.00 | | 411 138.00 |
DG Other reserves | 204 685.00 | 204 685.00 | | 204 685.00 |
DH Retained earnings | 5 115 230.00 | 5 707 434.00 | | 5 115 230.00 |
DI RESULTS FOR THE YEAR (Profit or Loss) | -163 174.00 | -592 204.00 | | -163 174.00 |
DK Regulated provisions | 306 508.00 | 306 508.00 | | 306 508.00 |
DL TOTAL (I) | 13 063 742.00 | 13 226 915.00 | | 13 063 742.00 |
DP Provisions for Risks | 335 421.00 | 397 677.00 | | 335 421.00 |
DR TOTAL (IV) | 335 421.00 | 397 677.00 | | 335 421.00 |
DV Miscellaneous Loans and Financial Debts (4) | 235 463.00 | 130 530.00 | | 235 463.00 |
DX Trade payables and related accounts | 944 841.00 | 952 478.00 | | 944 841.00 |
EC TOTAL (IV) | 1 180 304.00 | 1 083 008.00 | | 1 180 304.00 |
EE Grand total (I to V) | 14 579 467.00 | 14 707 600.00 | | 14 579 467.00 |
EI Including equity loans | 235 463.00 | | | 235 463.00 |
| |
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
FD Production sold - goods | | | 782 677.00 | |
FJ Net sales | | | 782 677.00 | |
FP Reversals of depreciation and provisions, transfer of expenses | | | 63 024.00 | |
FR Total operating income (I) | | | 845 701.00 | |
FW Other purchases and external expenses | | | 30 607.00 | |
FX Taxes, duties, and similar payments | | | 1 755.00 | |
FY Salaries and Wages | | | | |
FZ Social Security Contributions | | | | |
GE Other Expenses | | | -73 544.00 | |
GF Total Operating Expenses (II) | | | -41 182.00 | |
GG - OPERATING RESULT (I - II) | | | 886 883.00 | |
GP Total financial income (V) | | | | |
GV - FINANCIAL INCOME (V - VI) | | | | |
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) | | | 886 883.00 | |
| |
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | | |
HH Total exceptional expenses (VIII) | 818 382.00 | 927 852.00 | | 818 382.00 |
HI - EXCEPTIONAL RESULT (VII - VIII) | -818 382.00 | -927 852.00 | | -818 382.00 |
HK Income tax | 231 675.00 | 130 530.00 | | 231 675.00 |
HL TOTAL REVENUE (I + III + V + VII) | 845 701.00 | 638 042.00 | | 845 701.00 |
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) | 1 008 875.00 | 1 230 245.00 | | 1 008 875.00 |
HN PROFIT OR LOSS (Total revenue - Total expenses) | -163 174.00 | -592 205.00 | | -163 174.00 |
| |
| 5 - Fixed assets increase - decrease | Gross value at beginning of year - Item by item | Revaluation - Disposals | Acquisition - Gross value at year-end | |
0G ACQUISITIONS Total General Total | 16 008 257.00 | | | 16 008 257.00 |
CZ ACQUISITIONS: Establishment, Development, or Research Expenses | 63 949.00 | | | 63 949.00 |
I3 DECREASES Total Financial Fixed Assets | | 8 300 000.00 | 7 644 308.00 | |
I4 DECREASES Grand Total | | 8 300 000.00 | 7 708 257.00 | |
IN DECREASES Start-up, development, or research expenses | | | 63 949.00 | |
LQ ACQUISITIONS Total Financial Fixed Assets | 15 944 308.00 | | | 15 944 308.00 |
| |
| 6 - Depreciation | Amount at beginning of year | Increase: allocation for the year | Diminution reprise | Year-end amount |
0N DEPRECIATION Grand Total | 63 949.00 | | | 63 949.00 |
CY DEPRECIATION Start-up, development, or research expenses | 63 949.00 | | | 63 949.00 |
| |
| 7 - Provisions | Amount at beginning of year | Increase: allocation for the year | Diminution reprise | Year-end amount |
3X Extraordinary depreciation | | | | |
3Z Total regulated provisions | 306 508.00 | | | 306 508.00 |
4A Provisions for litigation | | | | |
5Z Total provisions for risks and expenses | 397 677.00 | | 62 256.00 | 397 677.00 |
| |
| 8 - Receivables and payables | Gross amount | Amount within 1 year | Amount 1 to 5 years | Amount more than 5 years |
8A Miscellaneous Loans and Financial Debts | 235 463.00 | 231 675.00 | 3 788.00 | 235 463.00 |
8B Suppliers and Related Accounts | 944 841.00 | 16 863.00 | 927 978.00 | 944 841.00 |
VT TOTAL – STATEMENT OF RECEIVABLES | | 248 538.00 | | |
VY TOTAL – STATEMENT OF LIABILITIES | 1 180 304.00 | 248 538.00 | 931 766.00 | 1 180 304.00 |
